Skip to main content

Articles

Original Research
Thromboembolic Events Associated with Bevacizumab plus Chemotherapy for Patients with Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials
Stakeholder Perspective
Better Patient Education Needed Regarding Thromboembolic Events Risk in Patients with Cancer
Read More
FDA Approvals
Innovation Tops Current Trends in the 2016 Oncology Drug Pipeline
Read More
FDA Approvals, In the News
FDA Approves First Blood Test to Detect Gene Mutation Associated with Non–Small-Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumors
Read More
Perspectives
In Silico Pharmacology
Read More
Original Research
The Prevalence and Determinants of Controlled Substance Discrepancies in a Level I Trauma Hospital
Stakeholder Perspective
Dramatic Increase in Misuse of Controlled Substances a Concern for All Stakeholders
Read More
Original Research
Benefits of Early Roflumilast Treatment After Hospital or Emergency Department Discharge for a COPD Exacerbation
Stakeholder Perspective
Continuing Challenges in COPD Management, Despite Its Prevalence and High Economic Burden
Read More
Practice Management
Increased Burden of Healthcare Utilization and Cost Associated with Opioid-Related Constipation Among Patients with Noncancer Pain
Stakeholder Perspective
Can Improved Management of Opioid-Induced Constipation Mitigate the Associated Costs?
Read More
Conference Highlights AMCP
Implications of Real-World Data and Pharmacoeconomics for Managed Care
Read More
Practice Management
Will the PCSK9 Inhibitors Be Employers’ “Line in the Sand”?
Read More
Page 111 of 245
Results 1101 - 1110 of 2441